APA (7th ed.) Citation

Hatanaka, T., Kakizaki, S., Hiraoka, A., Tada, T., Hirooka, M., Kariyama, K., . . . Shimada, N. (2023). Comparative efficacy and safety of atezolizumab and bevacizumab between hepatocellular carcinoma patients with viral and non‐viral infection: A Japanese multicenter observational study. Cancer Medicine, 12(5), 5293. https://doi.org/10.1002/cam4.5337

Chicago Style (17th ed.) Citation

Hatanaka, Takeshi, et al. "Comparative Efficacy and Safety of Atezolizumab and Bevacizumab Between Hepatocellular Carcinoma Patients with Viral and Non‐viral Infection: A Japanese Multicenter Observational Study." Cancer Medicine 12, no. 5 (2023): 5293. https://doi.org/10.1002/cam4.5337.

MLA (9th ed.) Citation

Hatanaka, Takeshi, et al. "Comparative Efficacy and Safety of Atezolizumab and Bevacizumab Between Hepatocellular Carcinoma Patients with Viral and Non‐viral Infection: A Japanese Multicenter Observational Study." Cancer Medicine, vol. 12, no. 5, 2023, p. 5293, https://doi.org/10.1002/cam4.5337.